Opiant Pharmaceuticals OPNT
$ 20.65
0.0%
Quarterly report 2022-Q3
added 11-14-2022
Country |
USA |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Roger Crystal |
Employees in the company |
21 |
Shares |
4.46 M |
Market Cap[1] |
$ 109 M |
EBITDA (LTM) |
$ -28.7 M |
P/E (LTM) |
-3.5 |
P/S (LTM) |
4.37 |
EPS (LTM) |
-5.9 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.